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Mutation of the p53 gene plays a critical role in the development of cancer and response to cancer therapy. To analyze the
mechanism of cancer development and to improve cancer therapy, it is important to assess which genes are downstream
components of p53 in cancers, and whether the expression levels of these genes affect p53-mediated apoptosis. In this study,
we transduced the wild type p53 gene along with the Apaf-1 and caspase-9 genes via adenovirus vectors into U251 and U-
373MG glioma cells harbouring a mutated p53, and evaluated the degree of apoptosis. Co-induction of Apaf-1 and caspase-9
genes highly enhanced p53-mediated apoptosis in glioma cells. Induction of wild type p53 enhanced the expression levels of
Bax, p21/WAF1, and Fas protein. To determine which gene is activated by wild type p53 induction and, in turn, activates
Apaf-1 and caspase-9, we transduced the Bax, p21/WAF1 or Fas gene via adenovirus vector to U251 cells to achieve a similar
expression level as that induced by the Adv for p53 in U251 cells. U251 cells transduced with Fas concomitant with the Apaf-
1 and caspase-9 genes underwent drastic apoptosis. This suggests that induction of wild type p53 upregulates Fas, which in
turn may play a role in the activation of Apaf-1 and caspase-9. These results are important for analyzing the mechanism of
tumour development and for predicting the therapeutic effect of p53 replacement gene therapy in a particular patient.
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The p53 gene is one of the most frequently mutated genes in
cancers, and inactivation of the p53 gene is critical in the develop-
ment and malignant progression of cancers. Genes that have been
reported to be involved in p53-mediated apoptosis include Bax
(Miyashita and Reed, 1995), Fas (Owen-Schaub et al, 1995) and
p53-inducible genes known as PIGs (Polyak et al, 1997). Recently,
Apaf-1 and caspase-9 were found to be essential downstream
components of p53 in Myc-induced apoptosis in early-passage
mouse embryonal ﬁbroblasts (Soengas et al, 1999). Therefore, it
would be interesting to know whether Apaf-1 and caspase-9 are also
downstream components of p53-mediated apoptosis in cancers.
To restore p53 function in cancers with mutated p53, p53 gene
replacement therapy using viral vectors has been performed. Trans-
fection of wild type p53 in in vitro and in vivo animal experiments
has been shown to induce apoptosis of various cancers (for review,
see Harris (1996), as well as in a clinical study (Roth et al, 1996)).
Roth et al (1996) reported that in six of nine patients with lung
cancer who underwent retrovirus-mediated transfer of the p53
gene, tumour regression or growth stabilization occurred without
vector-related toxic effects. However, some tumours are resistant
to p53 gene therapy. To be able to predict the effect of p53 gene
therapy in a particular patient, it would be important to evaluate
which genes are closely involved in p53-mediated apoptosis in
cancers. Moreover, transduction of those genes into cancers may
be beneﬁcial in augmenting the effect of p53 gene therapy. In this
study, we evaluated whether induction of the Apaf-1 and/or
caspase-9 genes increases the degree of p53-mediated apoptosis,
and found that co-induction of Apaf-1 and caspase-9 genes highly
augments p53-mediated apoptosis in gliomas.
MATERIALS AND METHODS
Cell lines
The U-373MG glioma cell line was obtained from American Type
Culture Collection (ATCC, Manassas, VA, USA). The U251 glioma
line was obtained from the Tumor Registry at the Division of
Cancer Treatment, National Cancer Institute (Frederick, MD,
USA). Each cell line was maintained as described previously
(Shinoura et al, 1998).
Generation of the adenoviral vectors
The XhoI/PstI fragment from pSXVtat-hp21 containing the full-
length human p21/WAF1 cDNA, which was kindly provided by
Dr Koh (Massachusetts General Hospital Cancer Center, Charles-
town, MA, USA), was inserted into the XhoI/PstI site of
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pSK+hp21. The XhoI/BamHI site of pSK+hp21 was inserted into
the XhoI/BglII site of pCAcc (Yoshida and Hamada, 1997), which
generated pCA-hp21. The cosmid pAxCA-hp21 was generated by
inserting the SalI/HindIII expression cassette (blunt end) from
pCA-hp21 into the SwaI site of the cosmid pAxcw.
Adenovirus (Adv) for Apaf-1 (Adv-APAF1), the Adv for
caspase-9 (Adv-Casp9), Adv for Bax (Adv-Bax), Adv for Fas
(Adv-Fas), and the Adv for p53 (Adv-p53) were generated and
transduced to cells as described previously (Takayama et al, 1998;
Shinoura et al, 1999a, 2000a,b). The total multiplicities of infection
(MOIs) of adenovirus used to infect each cell preparation was kept
the same in all experiments by supplementing with the Adv with
deleted E1 and E3 (Adv-dE) (Kanegae et al, 1995).
Assessment of cell death
The degree of cell death was assessed by determining the percen-
tage of cells that had died, and the degree of DNA
fragmentation, as described previously (Shinoura et al, 1999a).
Electron microscopic analysis for apoptotic cell death was
performed as described previously (Shinoura et al, 1998).
Detection of Fas
FACS analysis of Fas expression on the cell surface was performed
as described previously (Shinoura et al, 1998).
Immunoblot analysis
Immunoblot analysis was performed using the ECL kit (Amersham,
Buckinghamshire, UK), as previously described (Shinoura et al,
1998). The primary antibodies we used were: mouse anti-human
caspase-3 antibody (Transduction Laboratories, #C31720, Lexing-
ton, KY, USA), mouse anti-poly(ADP-ribose) polymerase (PARP)
monoclonal antibody (BIOMOL Research Laboratories, USA-250,
Plymouth Meeting, PA, USA), mouse anti-human p53 monoclonal
antibody (Oncogene Science, #OP09, Cambridge, MA, USA),
mouse anti-human Bax monoclonal antibody (Medical and Biolo-
gical Laboratories, #M010-3, Nagoya, Japan), rabbit anti-human
Bcl-x polyclonal antibody (Transduction Laboratories, #B22630,
Lexington, KY, USA), rabbit anti-human caspase-9 polyclonal anti-
body (IMGENEX, #IMG-123, San Diego, CA, USA), rabbit anti-
Apaf-1 polyclonal antibody (ProSci, #2013, Poway, CA, USA),
mouse anti-human p21 monoclonal antibody (Pharmingen,
#15091A), and mouse anti-b-actin monoclonal antibody (Sigma,
#A-5441, St. Louis, MO, USA). The secondary antibodies we used
were: horseradish peroxidase-conjugated rabbit anti-mouse
IgG+A+M (H+L) (Zymed Laboratories, #61-6420, San Francisco,
CA, USA) for caspase-3, PARP, p53, Bax, p21 and b-actin, or
horseradish peroxidase-conjugated donkey anti-rabbit IgG
[F(ab')2] (Amersham, #NA9340) for Apaf-1, caspase-9 and Bcl-XL.
RESULTS
Co-transduction of Apaf-1 and caspase-9 highly enhanced
p53-mediated apoptosis in gliomas
To investigate whether transduction of Apaf-1 or caspase-9
augments p53-mediated apoptosis, we selected the U251 and U-
373MG glioma cell lines which show a similar level of susceptibility
for Adv infection (Shinoura et al, 2000a). Transfection of Adv-p53
into U251 cells, as well as into U-373MG cells, induced the expres-
sion of exogenous wild type p53 (Figure 1, lanes 2, 4, 6, 8), the size
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Figure 1 Immunoblot analysis of p53, Apaf-1, caspase-9 and b-actin protein extracted from U251 and U-373MG cells 48 h after being infected with Adv-
p53, Adv-APAF1, Adv-Casp9, Adv for NCre (Adv-Cre) or Adv-dE in the indicated combinations. The MOI of Adv used to infect each glioma cell prepara-
tion is noted in parentheses. The total MOI was kept constant by supplementing with Adv-dE. Lane 1, U251 cells infected with Adv-dE (400); Lane 2, U251
cells co-infected with Adv-p53 (100) and Adv-dE (300); Lane 3, U251 cells co-infected with Adv-APAF1 (100), Adv-Casp9 (100), Adv-Cre (100) and Adv-
dE (100); Lane 4, U251 cells co-infected with Adv-p53 (100), Adv-APAF-1 (100), Adv-Casp9 (100) and Adv-Cre (100); Lane 5, U-373MG cells infected
with Adv-dE (400); Lane 6, U-373MG cells co-infected with Adv-p53 (100) and Adv-dE (300); Lane 7, U-373MG cells co-infected with Adv-APAF1 (100),
Adv-Casp9 (100), Adv-Cre (100) and Adv-dE (100); Lane 8, U-373MG cells co-infected with Adv-p53 (100), Adv-APAF-1 (100), Adv-Casp9 (100) and
Adv-Cre (100).
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British Journal of Cancer (2002) 86(4), 587–595 ã 2002 Cancer Research UKof which is larger than that of endogenous mutated p53 (Figure 1,
lanes 1, 3, 5, 7). Transfection of Adv-Casp9 induced the expression
of caspase-9 (Figure 1, lanes 3, 4, 7, 8). Transfection of Adv-APAF1
into these two cell lines enhanced the expression of Apaf-1 (Figure
1, lanes 3, 7). As shown in Figure 1, the molecular weight (Mr)o f
endogenous, mutant p53 in U251 cells (Figure 1, lanes 1, 3) and in
U-373MG cells (Figure 1, lanes 5, 7) is smaller than that of wild
type p53 in the respective cells (Figure 1, lanes 2, 4, 6, 8). It has
been reported that U251 and U-373MG cells carry a point muta-
tion in codon 273 of the p53 gene (Van Meir et al, 1994). The
expression level of endogenous caspase-9 in U251 and U-373MG
cells was much lower than that of exogenous caspase-9 induced
by Adv-Casp9 infection.
We evaluated the effect of co-infecting Adv-p53, Adv-APAF1
and Adv-Casp9 into U251 and U-373MG cells on the degree of cell
death and DNA fragmentation. The resultant percentage of cell
death and degree of apoptosis, which was assessed by the degree
of DNA fragmentation, in both cell lines were analyzed. U251
(Figure 2A-1) and U-373MG (Figure 2A-2) cells that had been
co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9, were effec-
tively killed 3 days after infection. The percentage of cells that had
died among U251 cells and among U-373MG cells co-infected with
Adv-p53, Adv-APAF1 and Adv-Casp9 (80+1.3 and 72+1.3%,
respectively) was much higher than the percentage of cells that
had died among U251 cells and U-373MG cells infected with
Adv-p53 alone (17+1.9 and 22+3.0%, respectively), or co-
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(4), 587–595infected with Adv-APAF1 and Adv-Casp9 (14+1.9 and 13+2.9%,
respectively) (Figure 2B).
The Br-dUTP uptake assay for the detection of DNA fragments
revealed that in U251 cells, 49% of the cells co-infected with Adv-
p53, Adv-APAF1 and Adv-Casp9 contained fragmented DNA, while
less than 2% of the cells infected with one or two of Adv-p53, Adv-
APAF1, and Adv-Casp9 contained fragmented DNA (Figure 2C-1).
Although the degree of apoptosis in U-373MG cells infected with
Adv-p53 was more remarkable than that in U251 cells infected with
Adv-p53, the U-373MG cells showed a similar pattern (Figure 2C-
2). The percentage of cells with fragmented DNA among U-373MG
cells co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9 was
70%, whereas that among U-373MG cells infected with one or two
of Adv-p53, Adv-APAF1 and Adv-Casp9 was less than 3%, except
among the cells co-infected with Adv-p53 and Adv-APAF1 (11%)
or with Adv-p53 and Adv-Casp9 (14%) (Figure 2C-2).
These results indicate that co-infection of Adv-p53, Adv-APAF1
and Adv-Casp9 induced remarkably enhanced apoptotic cell death
in comparison with that induced by single or double infection of
Adv-p53, Adv-APAF1 or Adv-Casp9 in the two glioma cell lines.
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British Journal of Cancer (2002) 86(4), 587–595 ã 2002 Cancer Research UKElectron microscopic analysis of glioma cells co-infected with
Adv-p53, Adv-APAF1 and Adv-Casp9, revealed apoptotic bodies
(Figure 2D: lower left panel) and condensed chromatin in the
nuclei (Figure 2D: lower middle panel) 3 days after infection. These
are features of apoptotic cell death. Moreover, as early as day 1
after co-infection of Adv-p53, Adv-APAF1 and Adv-Casp9 in U-
373MG cells, most of the mitochondria were damaged (Figure
2D: lower right panel), while infection of Adv-dE did not induce
damage to the mitochondria (Figure 2D: upper right panel).
To evaluate the mechanism of apoptosis induced by co-infection
with Adv-p53, Adv-APAF1 and Adv-Casp9 in glioma cells, we
examined the expression of apoptosis-related genes including
Bax, p21/WAF1, Bcl-XL, caspase-3, PARP and Fas. It was found
that p53 gene transfection increased the expression levels of Bax
and p21/WAF1 in U251 and U-373MG cells (Figure 3A, lanes 2,
4, 6 and 8), and Bcl-XL in U251 cells (Figure 3A, lanes 2 and 4).
In both cells co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9
(Figure 3A, lanes 4 and 8), anti-Bax antibody recognized a 21-kDa
protein and an 18-kDa protein, the latter of which has been
reported to play a role in the regulation of apoptosis (Oltvai et
al, 1993; Thomas et al, 1996). Induction of p53 alone and induc-
tion of Adv-p53, Adv-APAF1 and Adv-Casp9 induce markedly
increased and similar expression of Fas (Figure 3B). In U-373MG
cells, the expression level of caspase-3 after co-infection of Adv-
p53, Adv-APAF1 and Adv-Casp9 (Figure 3A, lane 8) was reduced
in comparison with that after infection of Adv-p53 or co-infection
of Adv-APAF1 and Adv-Casp9. This suggests that some of the
caspase-3 molecules in the U-373MG cells co-infected with Adv-
p53, Adv-APAF1 and Adv-Casp9, were cleaved, although the anti-
body used in this study did not recognize the cleaved product of
caspase-3. In accordance with this result, the majority of the PARP
molecules in the U-373MG cells co-infected with Adv-p53, Adv-
APAF1 and Adv-Casp9, was the cleaved form (p85), a substrate
on which caspase-3 acts (Figure 3A, lane 8).
Induction of Fas greatly enhanced Apaf-1- and
caspase-9-mediated apoptotic cell death in U251 cells
It has been reported that the apoptosis-related gene involved in
p53-mediated apoptosis may be Bax (Miyashita and Reed, 1995)
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Figure 2 (A) Microscopic photographs of U251 (A-1) and U-373MG (A-2) cells that had been infected with Adv-p53 (MOI 100); Adv-APAF1 (MOI
100), and Adv-Casp9 (MOI 100); Adv-p53 (MOI 100), Adv-APAF1 (100), and Adv-Casp9 (100); or Adv-dE. The cells were examined 3 days after infection
(original magniﬁcation 6100). The total MOI in all of the experiments was kept the same by supplementing with Adv-dE. (B) Percentage of cells that had
died among U251 and U-373MG cells, measured by trypan blue exclusion 3 days after infection with Adv-p53 (MOI 100), Adv-APAF1 (MOI 100), Adv-
Casp9 (MOI 100), or Adv-dE, or co-infection of these Advs. The total MOI was kept constant by supplementing with Adv-dE. The mean+standard devia-
tion of the percentage of dead cells in three preparations of two independent experiments is shown. (C) DNA fragmentation of U251 (C-1) or U-373MG
(C-2) cells infected with Adv-p53 (MOI 100), Adv-APAF1 (MOI 100), Adv-Casp9 (MOI 100), or Adv-dE, or co-infected with the indicated combinations of
these Advs. The total MOI was kept constant by supplementing with Adv-dE. The assay was performed as described in the Materials and Methods 3 days
after infection. The X-axis represents the propidium iodide-related ﬂuorescence and the Y-axis represents the Br-dUTP-related ﬂuorescence. The points in
the upper left and upper right areas of each panel represent apoptotic cells with fragmented DNA. (D) Ultrastructural analysis of U251 and U-373MG cells
after being co-infected with Adv-p53 (MOI 100), Adv-APAF1 (MOI 100) and Adv-Casp9 (MOI 100), or infected with Adv-dE. The total MOI was kept
constant. Upper left panel: U251 cells 3 days after being infected with Adv-dE (68000); upper middle panel: U-373MG cells 3 days after being infected
with Adv-dE (67000); upper right panel: U-373MG cells 1 day after being infected with Adv-dE (640000); lower left panel: U251 cells 3 days after being
co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9 (65000); lower middle panel: U-373MG cells 3 days after being co-infected with Adv-p53, Adv-
APAF1 and Adv-Casp9 (68000); lower right panel: U-373MG cells 1 day after being co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9 (68000). One
day after being co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9 (640000), most of the U-373MG cells showed mitochondrial damage (arrowhead
in lower right panel) despite a normal nucleus, whereas 1 day after being infected with Adv-dE, U-373MG cells showed normal mitochondria (arrowhead in
upper right panel) and nucleus. Apoptotic bodies (lower left panel) and condensation of chromatin (arrow in lower middle panel) were present in U251 and
U-373MG cells 3 days after being co-infected with Adv-p53, Adv-APAF1 and Adv-Casp9.
Apoptosis by co-induction of p53, Apaf-1 and caspase-9
N Shinoura et al
591
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(4), 587–595G
e
n
e
t
i
c
s
a
n
d
G
e
n
o
m
i
c
s
Bax
Bcl-XL
p21
caspase-3
PARP
–21kD
–26kD
–21kD
–32 kD
–116 kD
–85 kD
– + – + – + – + Adv-p53
– – + + – – + + Adv-APAF1
– – + + – – + + Adv-Casp9
+ + + – + + + – Adv-dE
1234 56 78
U251 U-373MG A
B
U251
0
3
0
6
0
9
0
1
2
0
1
5
0
C
o
u
n
t
s
U-373MG
0
3
0
6
0
9
0
1
2
0
1
5
0
C
o
u
n
t
s
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
1 23 4 5 1 23 45
Figure 3 (A) Immunoblot analysis of Bax, Bcl-XL, p21, caspase-3, PARP and b-actin protein extracted from U251 and U-373MG cells 48 h after being
infected with Adv-p53 (MOI 100), Adv-APAF1 (MOI 100), Adv-Casp9 (100) or Adv-dE, or co-infected with various combinations of these Advs. The MOI
of each Adv used to infect the particular glioma cell preparation is the same as that in Figure 1. The control for equal protein loading in the lanes is the same
as that in Figure 1. (B) Expression of Fas on the surface of U251 and U-373MG cells as measured by FACS after being infected with Adv-p53, Adv-APAF1,
Adv-Casp9, or Adv-dE, or co-infected with various combinations of these Advs. U251 and U-373MG cells were stained with anti-Fas antibody as described
in the Materials and Methods. The total MOI was kept constant by supplementing with Adv-dE. The data are presented as the log peak ﬂuorescence in-
tensity of each cell line infected with the indicated adenovirus(es) and stained with the indicated antibody: (1) isotype-matched control 2 days after being
infected with Adv-dE (MOI 400); (2) anti-Fas antibody 2 days after being infected with Adv-dE (MOI 400); (3) anti-Fas antibody 2 days after being co-in-
fected with Adv-p53 (MOI 100) and Adv-dE (MOI 300); (4) anti-Fas antibody 2 days after being co-infected with Adv-APAF1 (MOI 100), Adv-Casp9 (MOI
100), Adv-Cre (MOI 100) and Adv-dE (MOI 100); and (5) anti-Fas antibody 2 days after being co-infected with Adv-p53 (MOI 100), Adv-APAF1 (MOI
100), Adv-Casp9 (MOI 100), and Adv-Cre (MOI 100).
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Figure 4 (A) Immunoblot analysis of Bax and b-actin protein extracted from U251 cells 48 h after being infected with Adv-p53, Adv-Bax and/or Adv-dE
at various MOIs. The MOI of each Adv used to infect U251 cells is noted in parentheses. The total MOI was kept constant by supplementing with Adv-dE.
Lane 1, U251 cells infected with Adv-dE (150); Lane 2, U251 cells co-infected with Adv-p53 (100) and Adv-dE (50); Lane 3, U251 cells co-infected with
Adv-Bax (10), Adv-Cre (5) and Adv-dE (135); Lane 4, U251 cells co-infected with Adv-Bax (30), Adv-Cre (15) and Adv-dE (105); Lane 5, U251 cells co-
infected with Adv-Bax (100) and Adv-Cre (50). (B) Immunoblot analysis of p21 and b-actin protein extracted from U251 cells 48 h after being infected with
Adv-p53, Adv-p21 and/or Adv-dE at various MOIs. The MOI of each Adv used to infect U251 cells is noted in parentheses. The total MOI was kept constant
by supplementing with Adv-dE. Lane 1, U251 cells infected with Adv-dE (100); Lane 2, U251 cells infected with Adv-p53 (100); Lane 3, U251 cells co-
infected with Adv-p21 (10) and Adv-dE (90); Lane 4, U251 cells co-infected with Adv-p21 (30) and Adv-dE (70); Lane 5, U251 cells infected with
Adv-p21 (100). (C) Expression of Fas on the surface of U251 cells as measured by FACS after being infected with Adv-p53, Adv-Fas or Adv-dE, or
Apoptosis by co-induction of p53, Apaf-1 and caspase-9
N Shinoura et al
593
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(4), 587–595or Fas (Owen-Schaub et al, 1995). The p21/WAF1 gene is under
the transcriptional control of p53 (el-Deiry et al, 1993). To eval-
uate through which gene p53 activates the Apaf-1 and caspase-9
genes, we co-infected the Adv for Bax (Adv-Bax), Adv for p21
(Adv-p21) or Adv for Fas (Adv-Fas) along with Adv-APAF1
and Adv-Casp9, and analyzed the degree of apoptosis. First, we
determined the MOI of Adv-Bax, Adv-p21 or Adv-Fas that
induces a similar level of Bax, p21 or Fas protein expression,
respectively, as that after infection of Adv-p53 at an MOI of
100. Infection of Adv-Bax at an MOI of 10 (Figure 4A, lane 3)
induced a similar level of Bax protein expression as that after
infection of Adv-p53 at an MOI of 100 (Figure 4A, lane 2). Infec-
tion of Adv-p21 at an MOI of 30 (Figure 4B, lane 4) induced a
similar level of p21 protein expression as that after infection of
Adv-p53 at an MOI of 100 (Figure 4B, lane 2). Infection of
Adv-Fas at an MOI of 100 (Figure 4C, No. 6) induced a similar
level of Fas protein expression as that after infection of Adv-p53
at an MOI of 100 (Figure 4C, No. 3). Therefore, we infected Adv-
Bax (MOI 10), Adv-p21 (MOI 30) or Adv-Fas (MOI 100) along
with Adv-APAF1 and Adv-Casp9, and assessed the degree of
apoptosis. The percentage of cells with fragmented DNA induced
by co-infection of Adv-Bax, Adv-APAF1 and Adv-Casp9 in
U251 cells was only 0.6% (Figure 4D, lower second left panel).
Similarly, the percentage of cells with fragmented DNA in U251
cells co-infected with Adv-p21, Adv-APAF1 and Adv-Casp9, was
only 0.5% (Figure 4D, lower second right panel). In contrast,
U251 cells co-infected with Adv-Fas, Adv-APAF1 and Adv-Casp9
showed a drastically increased degree of apoptosis as high as
79% (Figure 4D, lower right panel), in comparison with that in
U251 cells infected with Adv-Fas alone (10%) (Figure 4D, upper
right panel). These results indicate that the upregulation of Fas by
p53 might play an important role in the apoptosis induced by co-
infection of Adv-p53, Adv-APAF1 and Adv-Casp9.
DISCUSSION
In this study, we found that co-induction of Apaf-1 and caspase-9
greatly enhanced p53-mediated apoptotic cell death in comparison
with that induced by the single induction of Apaf-1 or caspase-9.
Caspase-9 associates with Apaf-1, and oligomerization of this
complex in the presence of cytochrome c and dATP initiates the
postmitochondrial-mediated caspase cascade by proteolytic activa-
tion of effector caspases, resulting in apoptosis (Li et al, 1997;
Zou et al, 1997; Srinivasula et al, 1998). Indeed, electron micro-
scopic analysis revealed damage of the mitochondria as early as 1
day after co-infection of Adv-p53, Adv-APAF1, and Adv-Casp9
in glioma cells (Figure 2D), suggesting that damage of the mito-
chondria preceded apoptotic cell death. How did p53 activate
Apaf-1 and caspase-9? Several genes including Bax, p21 and Fas,
have been reported to be upregulated by induction of p53 (Waga
et al, 1994; Miyashita and Reed, 1995; Owen-Schaub et al, 1995).
We transduced a similar amount of Bax, p21 or Fas protein into
U251 cells via Adv vectors, as the level of the respective protein
induced by p53. Transduction of Fas augmented Apaf-1- and
caspase-9-mediated apoptosis (Figure 4D). Different genes such
as Bax might be involved in p53-mediated activation of Apaf-1
and caspase-9 when p53 is transduced at a higher level. However,
Fas played a critical role in activating Apaf-1 and caspase-9 at a
relatively low level of transduction of p53 gene that did not induce
drastic apoptosis. Indeed, in U251 and U-373MG cells, Adv-Fas-
induced apoptosis was blocked by transduction of CrmA, inhibitor
of caspase-8, which eventually activated downstream caspases by
direct cleaving or inducing cytochrome c release from the mito-
chondria, resulting in the formation of Apaf-1/cytochrome c/
caspase-9 complex (data not shown) (el-Deiry et al, 1993; Muzio
et al, 1996; Zou et al, 1997; Budihardjo et al, 1999; Shinoura et
al, 1999b; Slee et al, 1999). However, because Apaf-1, caspase-9
and cytochrome c form apoptosome in the presence of dATP,
which activates the postmitochondrial-mediated caspase cascade,
resulting in apoptosis, another factor needed for the enhancement
of p53-inducing apoptosis by co-induction of Apaf-1 and caspase-9
might be several mitochondrial proteins that are induced by p53 as
the direct-targets, such as Noxa and Puma (Oda et al, 2000; Naka-
no and Wousden, 2001). Further investigations are needed to
decide the factors for the enhancement of p53-inducing apoptosis
by co-induction of Apaf-1 and caspase-9.
Since mutation of the p53 gene is the most frequently-detected
abnormality in human tumours, gene therapy speciﬁcally targeting
tumour cells with mutated p53 has been performed. Preclinical and
clinical (Phase I) studies have shown that restoring p53 function
induces apoptosis and regression of tumours, suggesting that this
therapy is feasible and safe (Roth et al, 1996). Therefore, it would
be important to be able to predict the therapeutic effect of p53
gene therapy in a patient beforehand by analyzing the status of
p53 or expression levels of p53-related genes (Fulci et al, 1998).
Among gliomas, p53 gene therapy may be more effective on glio-
mas that express high levels of both Apaf-1 and caspase-9. In U251
and U-373MG cells, the endogenous level of Apaf-1 expression was
relatively high, whereas the endogenous level of caspase-9 expres-
sion was relatively low (Figure 1). An imbalance in the levels of
Apaf-1 and caspase-9 expression might render these gliomas resis-
tant to p53 gene therapy. The therapeutic effect of p53 gene
therapy has been shown to be augmented not only by chemother-
apy (Fujiwara et al, 1994) or radiotherapy (Badie et al, 1999), but
also by the induction of several genes including Fas (Rakkar et al,
1999), Fas ligand (Shinoura et al, 2000c) or p33
ING1 (Shinoura et
al, 1999c). Co-induction of Apaf-1 and caspase-9 enhanced the
degree of p53-mediated apoptosis, suggesting that co-induction
of p53, Apaf-1 and caspase-9 can be used as a modality for the
gene therapy of cancers. Further investigation is required to apply
this strategy to the gene therapy of gliomas.
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co-infected with various combinations of these Advs. The total MOI was kept constant by supplementing with Adv-dE. The data are presented as the log
peak ﬂuorescence intensity of U251 cells infected with the indicated adenovirus(es) and stained with the indicated antibody: (1) isotype-matched control 2
days after being infected with Adv-dE (MOI 150); (2) anti-Fas antibody 2 days after being infected with Adv-dE (MOI 150); (3) anti-Fas antibody 2 days after
being co-infected with Adv-p53 (MOI 100) and Adv-dE (MOI 50); (4) anti-Fas antibody 2 days after being co-infected with Adv-Fas (MOI 10), Adv-Cre
(MOI 5) and Adv-dE (MOI 135); (5) anti-Fas antibody 2 days after being co-infected with Adv-Fas (MOI 30), Adv-Cre (MOI 15) and Adv-dE (MOI 105); and
(6) anti-Fas antibody 2 days after being co-infected with Adv-Fas (MOI 100) and Adv-Cre (MOI 50). (D) DNA fragmentation of U251 cells infected with
Adv-Bax (MOI 10), Adv-p21 (MOI 30), Adv-Fas (MOI 100), Adv-APAF1 (MOI 100), Adv-Casp9 (MOI 100), Adv-dE, or co-infected with various combina-
tions of these Advs. The total MOI was kept constant by supplementing with Adv-dE.
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